2024:
"The New Role of Private Investment in Health Care Delivery," JAMA Health Forum, 5(2), February 2024, e240164 (with Zirui Song).
2023:
"National Health Expenditures: Reading Past The Headlines," Health Affairs Forefront, December 2023.
"Health System Change in the Wake of COVID-19," JAMA Health Forum, 4(10), October 2023, e234355.
"In Remembrance Of Victor Fuchs," Health Affairs Forefront, October 2023.
"What Artificial Intelligence Means for Health Care," JAMA Health Forum, 4(7), July 2023, e232652.
"Health Care in a Time of Deficit Concern," JAMA Health Forum, 4(3), March 2023, e230930.
2022:
"Health Workforce Issues More Conspicuous After Onset of COVID-19," JAMA Health Forum, 3(12), December 2022, e225256.
"Medicare Enters the Pharmaceutical Purchasing Business," JAMA Health Forum, 3(9), September 2022, e223630.
"The Costs of Long COVID," JAMA Health Forum, 3(5), July 2022, e221809.
[Update through July 2022: "The Economic Cost of Long COVID: An Update"]
"Challenges for the Beleaguered Health Care Workforce During COVID-19," JAMA Health Forum, 3(1), January 2022, e220143.
2021:
"Administrative Simplification and the Potential for Saving a Quarter-Trillion Dollars in Health Care," JAMA, 326(17), October 2021, 1677-1678 (with Nikhil R. Sahni and Brandon Carrus).
"How COVID-19 Changes the Economics of Health Care," JAMA Health Forum, 2(9), September 2021, e213309.
"The Increasing Role of Physician Practices as Bill Collectors: Destined for Failure," JAMA, 326(8), July 2021, 695-696.
"Which way will Biden go on health care?" JAMA Health Forum, 2(5), May 2021, e211280.
"Building Health Care Better Means Reining in Costs," JAMA Health Forum, 2(1), January 2021, e210117.
2020:
"The COVID-19 Pandemic and the $16 Trillion Virus," JAMA, 324(15), October 2020, 1495-1496 (with Lawrence H. Summers). cs_appendix.pdf
"Where Health Improvement Lags in Recent Decades--Pain and Mental Health," JAMA Health Forum, 1(10), October 2020, e201351.
"New Rules for the Pandemic Era," JAMA Health Forum, 1(7), July 2020, e200945.
"Strengthening The Medicare Trust Fund In The Era Of COVID-19," Health Affairs Blog, June 2020 (with Richard G. Frank, Jonathan Gruber, and Joseph P. Newhouse).
"Financing Drug Innovation in the US: Current Framework and Emerging Challenges," PharmacoEconomics, 38, May 2020, 905-911.
"The Business of Medicine in the Era of COVID-19," JAMA, 323(30), May 2020, 2003-2004 (with Sayeh Nikpay and Robert S. Huckman).
"How Will COVID-19 Affect the Health Care Economy?" JAMA Health Forum, 1(4), April 2020, e200419.
"Are Pharmaceutical Companies Earning Too Much?" JAMA, 323(9), March 2020, 829-830.
"Early returns from the era of precision medicine," JAMA, 323(2), January 2020, 109-110.
2019:
"Nursing Our Way to Better Health," JAMA 322(11), September 2019, 1033-1034.
"The Medical Hospital Readmission Reduction Program: Does It Do Any Good?" JAMA Internal Medicine, June 2019, 179(9), 1174-1175 (with Christopher Ody).
"Practical Steps to Make Health Care Better," JAMA, 321(20), May 2019, 1962-1963.
"Life and Death in Norway and the United States," JAMA, 321(19), May 2019, 1877-1879.
2018:
"With the 2020 Election Looming, Health Care Shapes Up (Again) as a Voting Issue," JAMA, December 2018.
“Extending the User Fee Approach to Pharmaceuticals,” JAMA, 320(15), October 2018, 1525-1526.
“A Breath of Bad Air: Cost of the Trump Environmental Agenda May Lead to 80,000 Extra Deaths per Decade,” JAMA, 319(22), June 2018 (with Francesca Dominici).
“The Good and Bad News of Health Care Employment,” JAMA, 319(8), February 2018, 758-759.
“What Is The US Health Spending Problem?” Health Affairs, 37(3), March 2018, 493-497.
2017:
“Rising Medical Costs Mean More Rough Times Ahead” JAMA, 318(6) August 2017, 508-509.
"Should Healthy People Have to Pay for Chronic Disease?" Washington Post, March 17, 2017.
2016:
“Health and Taxes,” JAMA, 316 (16), October 2016, 1634-1635.
“State Regulation of Freestanding Emergency Departments Varies Widely, Affecting Location, Growth, and Services Provided,” Health Affairs, 35 (10), October 2016, 1857-1866 (with Catherine Gutierrez, Rachel A. Lindor, Olesya Baker, and Jeremiah D. Schuur).
“Campaign Wars: Health Policy in a Fantasy World,” JAMA, 315(1), January 2016, 16-17.
2015:
“Insurers Again at Odds With Hospitals and Physicians,” JAMA, 314(13), October 2015, 1329-1330.
“From the Affordable Care Act to Affordable Care,” JAMA, 314(4), July 2015, 337-338.
“Payment Reform is about to Become a Reality,” JAMA, 313(16), April 2015, 1606-1607.
“A New Federal Health Care Strategy,” JAMA, 313(20), January 2015, 233-234.
2014:
“Who Benefits from Health System Change?” JAMA, 312(16), October 2014, 1639-1641.
2012:
“Potential Consequences of Reforming Medicare Into a Competitive Bidding System,” JAMA, 308(5), August 1, 2012, 459-460 (with Michael Chernew and Zirui Song).
“Paper Cuts: Reducing Health Care Administrative Costs,” Center for American Progress, June 2012 (with Elizabeth Wikler and Peter Basch).
“The Affordable Care Act is Constitutional,” Annals of Internal Medicine, 156(9), May 2012, 660-663 (with Jonathan Gruber).
“The Potential for Cost Savings through Bundled Episode Payments,” The New England Journal of Medicine, 366, March 2012, 1075-1077 (with Kaushik Ghosh).
2011 (and earlier):
“The ACO Rules — Striking the Balance between Participation and Transformative Potential,” The New England Journal of Medicine, 365(e6), July 2011, (with Meredith Rosenthal and Judith Feder).
“Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform,” The New England Journal of Medicine, 362, April 2010, 1553-1555 (with Wendy Everett).
“Will the Cost Curve Bend, Even without Reform?” The New England Journal of Medicine, 361, October 2009, 1424-1425.
“The Next Wave of Corporate Medicine: How We All Might Benefit,” The New England Journal of Medicine, 361, August 2009, 549-55.
“Health Care in the Next Administration,” The New England Journal of Medicine, 359(e17), October 2008 (with Gail Wilensky).
“The Demise of the Blockbuster?” The New England Journal of Medicine, 356, March 2007, 1292-1293.
“Disability and the Future of Medicare,” The New England Journal of Medicine, 349, September 2003, 1084-1085.